Bellevue Asset Management, LLC Sutro Biopharma, Inc. Transaction History

Bellevue Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$7.78 - $15.31 $645 - $1,270	-83 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$14.25 - $23.53 $71 - $117	-5 Reduced 5.68%	83 $1,000
Q2 2021 Aug 09, 2021	SELL	$18.03 - $23.82 $234 - $309	-13 Reduced 12.87%	88 $2,000
Q1 2021 May 12, 2021	BUY	$20.29 - $27.54 $791 - $1,074	39 Added 62.9%	101 $2,000
Q4 2020 Feb 11, 2021	BUY	$10.16 - $23.98 $629 - $1,486	62 New	62 $2,000

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $131M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellevue Asset Management, LLC with notifications on news.